BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16182312)

  • 1. Lower limb post-immobilization dystonia in Parkinson's disease.
    Singer C; Papapetropoulos S
    J Neurol Sci; 2005 Dec; 239(1):111-4. PubMed ID: 16182312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Off" painful dystonia in Parkinson's disease treated with botulinum toxin.
    Pacchetti C; Albani G; Martignoni E; Godi L; Alfonsi E; Nappi G
    Mov Disord; 1995 May; 10(3):333-6. PubMed ID: 7651452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin treatment of lateral axial dystonia in Parkinsonism.
    Bonanni L; Thomas A; Varanese S; Scorrano V; Onofrj M
    Mov Disord; 2007 Oct; 22(14):2097-103. PubMed ID: 17685467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reoperation for suboptimal outcomes after deep brain stimulation surgery.
    Ellis TM; Foote KD; Fernandez HH; Sudhyadhom A; Rodriguez RL; Zeilman P; Jacobson CE; Okun MS
    Neurosurgery; 2008 Oct; 63(4):754-60; discussion 760-1. PubMed ID: 18981887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.
    Giannantoni A; Rossi A; Mearini E; Del Zingaro M; Porena M; Berardelli A
    J Urol; 2009 Oct; 182(4):1453-7. PubMed ID: 19683298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dystonia in Parkinson's disease: clinical and pharmacological features.
    Poewe WH; Lees AJ; Stern GM
    Ann Neurol; 1988 Jan; 23(1):73-8. PubMed ID: 3345068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Parkinsonian dystonia].
    Dowsey-Limousin P
    Rev Neurol (Paris); 2003 Oct; 159(10 Pt 1):928-31. PubMed ID: 14615683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outlet type constipation in Parkinson's disease: results of botulinum toxin treatment.
    Cadeddu F; Bentivoglio AR; Brandara F; Marniga G; Brisinda G; Maria G
    Aliment Pharmacol Ther; 2005 Nov; 22(10):997-1003. PubMed ID: 16268975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease.
    Chastan N; Westby GW; Yelnik J; Bardinet E; Do MC; Agid Y; Welter ML
    Brain; 2009 Jan; 132(Pt 1):172-84. PubMed ID: 19001482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of injecting botulinum toxin type a into the calf muscles on freezing of gait in Parkinson's disease: a double blind placebo-controlled pilot study.
    Gurevich T; Peretz C; Moore O; Weizmann N; Giladi N
    Mov Disord; 2007 Apr; 22(6):880-3. PubMed ID: 17290455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin type A for drooling in Parkinson's disease: a double-blind, randomized, placebo-controlled study.
    Lagalla G; Millevolte M; Capecci M; Provinciali L; Ceravolo MG
    Mov Disord; 2006 May; 21(5):704-7. PubMed ID: 16440332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin-A injections via electrical motor point stimulation to treat writer's cramp: pilot study.
    Lim EC; Quek AM; Seet RC
    Neurol Neurophysiol Neurosci; 2006 Jun; ():4. PubMed ID: 17260081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relative preservation of thalamic centromedian nucleus in parkinsonian patients with dystonia.
    Truong L; Brooks D; Amaral F; Henderson JM; Halliday GM
    Mov Disord; 2009 Oct; 24(14):2128-35. PubMed ID: 19735086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postural reactions to soleus muscle vibration in Parkinson's disease: scaling deteriorates as disease progresses.
    Valkovic P; Krafczyk S; Bötzel K
    Neurosci Lett; 2006 Jun; 401(1-2):92-6. PubMed ID: 16574321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The physiological effects of pallidal deep brain stimulation in dystonia.
    Tisch S; Rothwell JC; Limousin P; Hariz MI; Corcos DM
    IEEE Trans Neural Syst Rehabil Eng; 2007 Jun; 15(2):166-72. PubMed ID: 17601185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Camptocormia: pathogenesis, classification, and response to therapy.
    Azher SN; Jankovic J
    Neurology; 2005 Aug; 65(3):355-9. PubMed ID: 16087897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adult-onset primary focal foot dystonia.
    Singer C; Papapetropoulos S
    Parkinsonism Relat Disord; 2006 Jan; 12(1):57-60. PubMed ID: 16154790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pisa syndrome as a motor complication of Parkinson's disease.
    Kim JS; Park JW; Chung SW; Kim YI; Kim HT; Lee KS
    Parkinsonism Relat Disord; 2007 Mar; 13(2):126-8. PubMed ID: 16731022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin injections do not improve freezing of gait in Parkinson disease.
    Wieler M; Camicioli R; Jones CA; Martin WR
    Neurology; 2005 Aug; 65(4):626-8. PubMed ID: 16116132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin injections to one leg alleviate freezing of gait in a patient with Parkinson's disease.
    Giladi N; Honigman S
    Mov Disord; 1997 Nov; 12(6):1085-6. PubMed ID: 9399243
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.